This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
$1 buys you full access to ALL of TheStreet's Subscription Services! Learn More

European Stocks Rebound Amid M&A, Earnings Headlines

Stocks in this article: GEAZNULPFE

LONDON (The Deal) -- European stocks rebounded on Thursday amid mergers and acquisitions excitement and rash of first-quarter trading bulletins, while Asian indices were mixed after disappointing U.S. housing data.

In London, the FTSE 100 was up 0.59% at 6,714.11. The DAX in Frankfurt climbed 0.68% to 9,609.36 and in Paris, the CAC 40 increased 0.82% to 4,487.47.

In Germany, the closely watched Ifo index of business confidence unexpectedly rose in April.

Shares in French engineering company Alstom SA posted gains well into the double digits after a Bloomberg report of a potential takeover agreement with General Electric (GE). Alstom issued a carefully worded statement which didn't deny that talks were taking place, saying it "is not informed of any potential public tender offer for the shares of the company" and that it constantly reviews its strategic options. Shares in Bouygues SA, the conglomerate that owns a 29% Alstom stake, were up 5%. Bloomberg said that Bouygues supported the Alstom bid.

In Vienna, Telekom Austria AG was up almost 7% after Carlos Slim's America Movil SAB de CV forged a shareholder pact with the Austrian government, triggering a 1.4 billion euros ($2 billion) bid for the outstanding shares.

Among the many companies to post quarterly earnings bulletins was Anglo-Swedish drugsmaker AstraZeneca (AZN), which last weekend was the rumored and apparently abortive target of a $100 billion bid from Pfizer (PFE).

AstraZeneca first-quarter revenue was little changed at $6.4 billion, with lost patents hampering revenue growth, while operating profit slid 40%, because of investment in new drugs. It made no mention of Pfizer's bid interest.

Its shares were up almost 3%, even though profit missed forecasts, as investors continued to bet that it will attract further bid interest.

Other companies whose shares rose after reporting first-quarter result included French oilfield services company Technip SA, which was up almost 7% after first-quarter net profit declined less than expected, and French electrical components maker Schneider SA, which posted strong first-quarter revenue growth in China and other emerging markets.

Staying in France, Air Liquide SA also rose on the back of a 6.2% increase in first-quarter sales as it pronounced a "return to a more favorable economic climate."

In the food and consumer goods sector, Anglo-Dutch Unilever (UL) declined after the impact of currency movements pushed first-quarter sales down 6.3% to 11.4 billion euros, though underlying sales growth was 3.6%.

And Dutch brewer Heineken also fell after posting a 2.6% decline in first-quarter sales to just over 4 billion euros, though the revenue picture was better than expected, with sales up 3.4% on what the company calls an "organic basis."

In Hong Kong the Hang Seng closed up 0.24% at 22,562.80, bucking a negative trend on mainland Chinese markets and most other Asian exchanges after an unexpected decline in March new home sales in the U.S, as measured by the Commerce Department.

In Tokyo the Nikkei 225 fell 0.97% to 14,404.99.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,810.06 +91.06 0.51%
S&P 500 2,063.50 +10.75 0.52%
NASDAQ 4,712.97 +11.1030 0.24%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs